Company intelligence / Profile preview

Evonik

Essen, North Rhine-Westphalia, Germanyevonik.com ↗
Ownership
Public · EVK
Employees
~33000
Development stage
Commercial
01

Overview

Evonik is one of the world’s leading specialty chemicals companies with a major focus on healthcare solutions. Its Health Care business unit serves over a thousand life science customers globally—including more than ninety percent of the world’s top pharmaceutical companies—by providing advanced excipients, proprietary drug delivery technologies, cell culture solutions, and comprehensive CDMO/CMO services. The company has decades-long expertise in oral and parenteral drug delivery systems such as EUDRAGIT®, RESOMER®, lipid-based formulations for mRNA therapeutics/vaccines, high-purity amino acids/proteins/peptides for cell culture media and bioprocessing. It played an important role during the COVID pandemic by supplying critical lipids used in mRNA vaccines. Recent investments include new R&D hubs in Boston/Cambridge MA and Allentown PA plus large-scale lipid production facilities to support next-generation medicines.

Modalities
Small molecules (APIs, HPAPIs)Monoclonal antibodiesPeptides and proteinsNucleic acids/mRNA/lipids for RNA deliveryCell therapies, gene therapies, viral vectors
Industry
Chemicals & Materials
02

Partnerships

Major partnerships with global pharmaceutical companies (>90% of top pharma)ST Pharm partnership to expand RNA/nucleic acid servicesmember of MIT Industrial Liaison Programcollaborations with academic institutions like MIT
03

Financials

Market cap
$0
Total revenue
$106.4M
Enterprise value
$68.1M

Beyond the preview

Go deeper on Evonik.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evonik.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call